» Articles » PMID: 38963023

Metformin Prevents the Onset and Progression of Intervertebral Disc Degeneration: New Insights and Potential Mechanisms (Review)

Overview
Journal Int J Mol Med
Specialty Genetics
Date 2024 Jul 4
PMID 38963023
Authors
Affiliations
Soon will be listed here.
Abstract

Metformin has been the go‑to medical treatment for addressing type 2 diabetes mellitus (T2DM) as a frontline oral antidiabetic. Obesity, cancer and bone deterioration are linked to T2DM, which is considered a metabolic illness. Numerous diseases associated with T2DM, such as tumours, cardiovascular disease and bone deterioration, may be treated with metformin. Intervertebral disc degeneration (IVDD) is distinguished by degeneration of the spinal disc, accompanied by the gradual depletion of proteoglycans and water in the nucleus pulposus (NP) of the IVD, resulting in lower back pain. The therapeutic effect of metformin on IVDD has also attracted much attention. By stimulating AMP‑activated kinase, metformin could enhance autophagy and suppress cell senescence, apoptosis and inflammation, thus effectively delaying IVDD. The present review aimed to systematically explain the development of IVDD and mechanism of metformin in the treatment and prevention of IVDD to provide a reference for the clinical application of metformin as adjuvant therapy in the treatment of IVDD.

References
1.
Tucker G, Casey C, Phillips P, Connor H, Ward J, Woods H . Metformin kinetics in healthy subjects and in patients with diabetes mellitus. Br J Clin Pharmacol. 1981; 12(2):235-46. PMC: 1401849. DOI: 10.1111/j.1365-2125.1981.tb01206.x. View

2.
He M, Lu B, Opoku M, Zhang L, Xie W, Jin H . Metformin Prevents or Delays the Development and Progression of Osteoarthritis: New Insight and Mechanism of Action. Cells. 2022; 11(19). PMC: 9563728. DOI: 10.3390/cells11193012. View

3.
Varde N, Pack D . Microspheres for controlled release drug delivery. Expert Opin Biol Ther. 2003; 4(1):35-51. DOI: 10.1517/14712598.4.1.35. View

4.
Yanovski J, Krakoff J, Salaita C, McDuffie J, Kozlosky M, Sebring N . Effects of metformin on body weight and body composition in obese insulin-resistant children: a randomized clinical trial. Diabetes. 2011; 60(2):477-85. PMC: 3028347. DOI: 10.2337/db10-1185. View

5.
Latifkar A, Ling L, Hingorani A, Johansen E, Clement A, Zhang X . Loss of Sirtuin 1 Alters the Secretome of Breast Cancer Cells by Impairing Lysosomal Integrity. Dev Cell. 2019; 49(3):393-408.e7. PMC: 6519475. DOI: 10.1016/j.devcel.2019.03.011. View